19th Annual National Interdisciplinary Breast Center Conference March 14-18, 2009 Specialized Pre-Conference Sessions March 14 & 15 Planet Hollywood Resort & Casino Las Vegas, NV

 

Saturday, March 14, 2009 7:00 AM - 6:30 PM	Sunday, March 15, 2009 7:00 AM - 12:00 PM
7:00 - 7:45 AM Breakfast	7:00 - 8:00 AM Breakfast
7:45 - 7:55 AM Welcome and Introduction Kevin S. Hughes, MD, FACP	Concurrent Breakout Sessions (Repeating at 9 and 10 AM)
8:00 - 8:30 AM Hereditary Breast and Ovarian Cancer: History and Evolution Henry Lynch, MD From his unique perspective as a pioneer in the field of cancer genetics, Dr. Lynch will describe the discovery of hereditary breast and ovarian cancer, the identification of the BRCA genes and current status of BRCA testing, as well as a look at the future of this field.	8:00 – 9:00 AM  & 10: 00 - 11:00 AM Nuts and Bolts of Risk Counseling Jennifer Scalia Wilbur, MS Establishing a cancer genetics clinic can bring with it many challenges. There are many successful programs as models, so why reinvent the wheel? This workshop will focus on the specific tools (i.e.: billing, forms, questionnaires,etc) necessary for program development.
8:30 - 9:00 AM Overview of Hereditary Cancer Genetics David Euhus, MD This session will provide a graphic and user-friendly description of genes involved in hereditary cancer development.	8:00 – 9:00 AM  & 10: 00 - 11:00 AM Clinical Management: Challenging Cases/Ask the Experts Victor Vogel, MD and David Euhus, MD Making clinical recommendations for high risk women is challenging as there are no textbook guidelines and many women will have uncertain risk status. Nevertheless, we are called on to advise. Participants are invited to bring challenging cases for the experts sort out and discuss.
9:00 - 10:00 AM What's New in Hereditary Breast and Ovarian Cancer Steven Narod, MD Researchers have identified features of BRCA related cancers and factors that may affect penetrance. This session will outline the latest findings regarding modifying risk factors that may help inform prevention and management strategies.	8:00 – 9:00 AM  & 10: 00 - 11:00 AM On the Frontline of Cancer Risk Counseling Connie Roche, ANP, BC, APNG, Dana Dowd, MS, RNC and Larry Geier, MD This session will be an open discussion and Q&A with the panelists and Dr. Lindner who will address challenges and solutions to provision of these services. Participants are invited to bring their own scenarios for discussions.
10:00 - 10:30 AM Break	11:00 - 11:30 AM Break
10: 30 - 11:20 AM Assessing Risk With and Without Models Victor Vogel, MD, MHS, FACP There are several models for assessing breast and ovarian cancer risk. This session will describe the origins, strengths and limitations of the commonly used risk prediction models. Guidance will also be provided for the many circumstances when eyeball pedigree analysis may trump the models.	11:30 AM – 12:00 PM Management of Breast Cancer in the Carrier Jeffrey Weitzel, MD BRCA1 associated breast cancers often have pathologic features that are distinct from those of sporadic cancers. In addition, risk of recurrence and second cancers are greater. This session will address how management options are affected by these factors and address current research in this area.
11:20 AM - 12:10 PM Hereditary Breast Cancer: The Magnitude of the Problem Kevin S. Hughes, MD, FACP The vast majority of BRCA carriers are unaware of their status, and the majority identified to date have already had cancer. We must identify these women before they develop cancer, and develop strategies to help prevent cancer or find it at an earlier stage. The magnitude of this problem will be discussed, and some thoughts on solving this issue will be presented.	12:00 – 12:30 PM Psychosocial Issues: What Have We Learned, How We Can Help Henry Lynch, MD Clinical management options have been developed because of data gathered from individuals and families who have undergone genetic testing over the past fifteen years. Less defined is the psychological impact following testing. This session will review current data regarding the impact of BRCA testing on individuals and families.
12:15 - 1:30 PM Lunch Deborah Lindner, MD Dr. Lindner, a practicing obstetrician/ gynecologist, will reflect on her personal experience with BRCA testing, decision-making regarding risk reduction choices, and impact on her personal and professional life.	12:30 PM Adjourn
1:30 - 3:00 PM How Did You Do It? Setting Up and Implementing a Risk Assessment Program Connie Roche, ANP, BC, APNG , Dana Dowd, MS, RNC, Larry Geier, MD and Jennifer Scalia Wilbur, MS Panelists from different disciplines and settings will describe the development and current status, strengths and weaknesses of their programs. Half of the session will be open for audience Q&A.
3:00 - 3:30 PM Break
3:30 - 4:00 PM Mri Screening for High Risk: Who, Why and How Long? Alan Semine, MD This session will describe rationale for use of MRI screening, identification of women for whom screening is appropriate and address whether age and breast density should be factored into decisions about screening recommendation.
4:00 - 4:30 PM Management of Breast Cancer Risk David Euhus, MD This session will outline current options and rationale for management of breast cancer risk in the BRCA carrier.
4:30 - 5:00 PM Management of Ovarian Cancer Risk Victor Vogel, MD, MHS, FACP This session will outline current options and rationale for management of ovarian cancer risk in the BRCA carrier.
5:00 - 5:30 PM Patterns of Cancer, Patterns of Care Jeffrey Weitzel, MD Focus for BRCA mutation carriers is on risk of female breast and ovarian cancers, but males are also at increased risk for breast cancer and data suggests there may be risk for other cancers. This session will address what is known about risk for male breast cancer, melanoma, and other cancers including prostate, pancreas, colon and  others. Any indicated screening and risk reduction strategies will be discussed.
5:30 - 6:30 PM Reception
Register early! Last year this course was full 30 days prior to the conference.